BASF expects strategy to grow despite challenging environment


- Last updated on GMT

Dr Kurt Bock says BASF "are well on track with our 'We create chemistry' strategy despite a challenging environment."
Dr Kurt Bock says BASF "are well on track with our 'We create chemistry' strategy despite a challenging environment."

Related tags Value added BASF

Chemicals company BASF says that it expects its 'We create chemistry' strategy to grow and make the company more profitable, despite a challenging environment, according to its chairman of the Board of Executive Directors.

Dr Kurt Bock made the statement at the BASF Investor Day 2015 in Ludwigshafen, saying that the Germany-headquartered firm expects chemical production to continue to grow well above global GDP until 2020.

Challenging environment

However, BASF does note that the business environment has changed since the company introduced its ‘We create chemistry’ strategy in 2011, and that many challenges lie ahead.

"Major markets did not grow as fast as anticipated​ [since 2011]. The oil price has been unpredictable and has decreased substantially. Geopolitics have contributed to higher volatility,"​ says Bock.

As a result, BASF has slightly adjusted its expectations for the global economic environment from 2015 to 2020 (compound annual growth rates; assumptions from 2011 in parentheses):

•             Growth of gross domestic product: 3.0% (3.2%)

•             Growth in industrial production: 3.5% (3.7%)

•             Growth in chemical production: 3.9% (4.0%)

What this means for the company is that the emerging markets will remain the global growth drivers, with Western Europe expected to get back on the growth path, but on a low level.

In the next years, the company says it aims to grow sales slightly faster than global chemical production; and wants to grow EBITDA well above global chemical production.

"We will continue to add value as one company. Our Verbund approach was the reason for our success over the past 150 years and it will serve us very well also in the future,"​ says Bock.

"We remain committed to deliver attractive returns. Our goal is to earn a significant premium on our cost of capital. We will continue our progressive dividend policy,"​ adds Dr Hans-Ulrich Engel, Chief Financial Officer of BASF.

Set goals

As such, in order to achieve its goals, BASF has set the following priorities for its business:

Innovations: aims to achieve its target of generating €10 billion of sales with products and solutions that have been on the market since 2010, and maintain its R&D spending at around 3% of sales excluding Oil & Gas.

Investments: aims to bring down capital expenditures to levels slightly above depreciation in the coming years.

Continuous portfolio management: add new specialty and solutions businesses through its innovation pipeline as well as acquisitions.

Sustainability: aims to further increase the proportion of products and solutions, which make a substantial sustainability contribution in the value chain.

Operational excellence: BASF has announced a further operational excellence program called DrivE – Drive Efficiency. It will run from 2016 to 2018 and targets an annual earnings contribution of €1 billion by the end of 2018.

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us


View more



Beauty 4.0 Podcast